What are the risks and benefits of the annual influenza (flu) vaccine for a healthy adult and how closely does it match the circulating virus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benefits and Risks of Annual Flu Vaccination for Healthy Adults

The annual influenza vaccine is highly recommended for healthy adults as it can prevent illness in 70-90% of recipients when the vaccine matches circulating strains well, reducing both personal morbidity and societal burden. 1

Effectiveness and Strain Matching

  • The effectiveness of influenza vaccines depends primarily on the match between vaccine strains and circulating viruses, as well as the age and immune competence of the recipient 1
  • When there is a good match between vaccine and circulating viruses, influenza vaccine prevents illness in approximately 70-90% of healthy adults under 65 years of age 1
  • Each year's influenza vaccine contains three virus strains (typically two type A and one type B) representing influenza viruses likely to circulate in the upcoming season 1
  • The World Health Organization determines which strains to include in each year's vaccine based on global surveillance data 2
  • Recent data from the 2023-24 season shows vaccine effectiveness against influenza A ranging from 27% to 46% for adults across healthcare settings, and 46% to 59% for children and adolescents 3
  • Vaccine effectiveness against influenza B was higher, ranging from 60% to 78% for adults across healthcare settings 3
  • During seasons with drifted viruses (antigenic changes), vaccine effectiveness may be lower but still provides substantial benefit, especially against severe outcomes 4

Benefits for Healthy Adults

  • Vaccination of healthy adults results in decreased work absenteeism and decreased use of healthcare resources 1
  • The vaccine reduces the risk of severe illness, hospitalization, and death from influenza 1
  • In a recent study during the 2019-2020 season (which had drifted viruses), vaccination reduced severe influenza-associated illness among adults by 32% 5
  • Vaccination was 80% effective in preventing influenza-associated death 5
  • Vaccination helps create herd immunity, protecting vulnerable populations who cannot be vaccinated or who respond poorly to vaccination 1
  • Annual vaccination is necessary because immunity declines in the year following vaccination 2

Risks and Side Effects

  • The influenza vaccine cannot cause influenza infection because it contains only noninfectious viruses that have been inactivated 2
  • The most common side effect is soreness at the injection site lasting up to 2 days, reported by less than one-third of vaccine recipients 2
  • Systemic reactions such as fever, malaise, and myalgia may occur infrequently, most often affecting persons with no prior exposure to influenza virus antigens 2
  • Guillain-Barré Syndrome (GBS) was identified among approximately 1 per 100,000 recipients of the 1976 swine influenza vaccine, but the risk from seasonal influenza vaccines is estimated at most to be 1-2 cases per million vaccinees 4
  • Immediate allergic reactions are rare but can occur in patients with egg hypersensitivity, as vaccines contain small amounts of egg protein 1

Special Considerations

  • Persons with severe egg allergies should consult a physician before receiving influenza vaccination 2
  • Influenza vaccination can be safely administered simultaneously with other vaccines, including pneumococcal vaccine, at different sites on the body 2
  • The vaccine is made from highly purified, egg-grown viruses that have been rendered noninfectious through inactivation processes 2

Practical Implications

  • The CDC recommends annual influenza vaccination for all persons aged ≥6 months, including healthy adults 3
  • Vaccination before the influenza season each year is the most effective means of reducing the impact of influenza 1
  • Even in years when vaccine effectiveness is moderate due to strain mismatches, vaccination still provides significant protection against severe outcomes including hospitalization and death 5
  • For healthy adults, the benefits of annual influenza vaccination substantially outweigh the minimal risks 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Influenza Vaccine Safety and Efficacy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Seasonal influenza vaccines.

Current topics in microbiology and immunology, 2009

Research

Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.